» Authors » Benjamin Kably

Benjamin Kably

Explore the profile of Benjamin Kably including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 210
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Launay M, Ollier E, Kably B, Le Louedec F, Thiery G, Lanoiselee J, et al.
Antibiotics (Basel) . 2024 Aug; 13(8). PMID: 39200056
To rapidly achieve ceftazidime target concentrations, a 2 g loading dose (LD) is recommended before continuous infusion, but its adequacy in critically ill patients, given their unique pharmacokinetics, needs investigation....
2.
Lafont E, Blez D, Bildan M, Veyer D, Pere H, Puech J, et al.
Clin Infect Dis . 2023 Dec; 79(3):798-800. PMID: 38159041
No abstract available.
3.
Gras E, Tran Y, Kably B, Lillo-Lelouet A, Caruba T, Sabatier B, et al.
Infection . 2023 Dec; 52(2):557-566. PMID: 38153684
Purpose: Major bleedings have been described with cefazolin. The objective was to determine the frequency of bleeding events in cefazolin-treated patients and to identify risk factors for these complications. Methods:...
4.
Mimram L, Magreault S, Kerroumi Y, Salmon D, Kably B, Marmor S, et al.
J Antimicrob Chemother . 2023 Oct; 78(12):2943-2949. PMID: 37883695
Background: Despite its important drug-drug interaction, combined clindamycin/rifampicin therapy may achieve effective plasma clindamycin concentrations, provided clindamycin is administered by continuous infusion. However, the precise clindamycin dose remains unknown. Objectives:...
5.
Dubert M, Kably B, Derobertmasure A, Podglajen I, Munte L, Clauss D, et al.
J Antimicrob Chemother . 2023 Oct; 78(12):2915-2918. PMID: 37878769
Objectives: Treating patients with infective endocarditis (IE) due to streptococci and enterococci currently involves high-dosage antibiotics. Recent literature suggests a 30%-70% diffusion rate could be extrapolated to human heart valve...
6.
Korb-Savoldelli V, Tran Y, Perrin G, Touchard J, Pastre J, Borowik A, et al.
J Med Internet Res . 2023 Oct; 25:e42384. PMID: 37843891
Background: Medication adherence plays a critical role in controlling the evolution of chronic disease, as low medication adherence may lead to worse health outcomes, higher mortality, and morbidity. Assessment of...
7.
Derobertmasure A, Kably B, Justin J, De Sousa Carvalho C, Billaud E, Boutouyrie P
J Chromatogr B Analyt Technol Biomed Life Sci . 2023 Mar; 1219:123539. PMID: 36867996
Cardiovascular pharmacological countermeasures will be required as a preventive measure of cardiovascular deconditioning and early vascular ageing for long term space travelers. Physiological changes during spaceflight could have severe implications...
8.
Mimram L, Magreault S, Kerroumi Y, Salmon D, Kably B, Marmor S, et al.
Antibiotics (Basel) . 2022 Nov; 11(11). PMID: 36358117
A population PK model of clindamycin orally administered to patients with prosthetic joint infections (PJIs) was developed using NONMEM 7.5. Monte-Carlo simulations were run to determine the probability of obtaining...
9.
Azizi M, Mahfoud F, Weber M, Sharp A, Schmieder R, Lurz P, et al.
JAMA Cardiol . 2022 Nov; 7(12):1244-1252. PMID: 36350593
Importance: Although early trials of endovascular renal denervation (RDN) for patients with resistant hypertension (RHTN) reported inconsistent results, ultrasound RDN (uRDN) was found to decrease blood pressure (BP) vs sham...
10.
Fanton dAndon C, Correia P, Rigaill J, Kably B, Perinel-Ragey S, Launay M
Expert Opin Drug Metab Toxicol . 2022 May; 18(4):277-284. PMID: 35583387
Introduction: Ceftazidime is used for the treatment of many bacterial infections, including severe infections. Like other beta-lactams, inter-individual variability in ceftazidime pharmacokinetics has been described. Due to its related pathophysiological...